Mackenzie Financial Corp Vista Gen Therapeutics, Inc. Transaction History

Mackenzie Financial Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 10, 2022	BUY	$0.88 - $1.73 $2,947 - $5,793	3,349 Added 32.26%	13,730 $12,000
Q4 2021 Feb 14, 2022	SELL	$1.67 - $2.76 $1,417 - $2,343	-849 Reduced 7.56%	10,381 $20,000
Q3 2021 Nov 08, 2021	BUY	$2.62 - $3.45 $29,422 - $38,743	11,230 New	11,230 $31,000

2.7M

Ticker VTGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 206,836,000
Market Cap $730M
Description
VistaGen Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing various medicines with the potential to care for anxiety, depression, and other disorders of the central nervous system (CNS). The company's CNS pipeline includes PH94B, a rapid-onset neuroactive nasal spray, which is in Phase III d...

Get notified when there are updates to the investment portfolio of Mackenzie Financial Corp, based on Form 13F filings with the SEC.

Stay updated on Mackenzie Financial Corp with notifications on news.